July 17, 2026 · Form 4 insider transaction
Herrmann Ken bought 3,065 shares of Aktis Oncology, Inc. at $0.08 per share, a transaction worth $245.20. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.